Corporate Banner
Satellite Banner
Technology
Networks
Scientific Communities
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Mettler-Toledo Offers Safe and Cost Effective Reaction Monitoring Solution

Published: Friday, November 09, 2012
Last Updated: Friday, November 09, 2012
Bookmark and Share
Stirling engine configuration for ReactIR 15™: Reliable use without nitrogen.

Mettler Toledo has announced that its ReactIR™ 15 Stirling Engine (SE) MCT model is now available. This compact, easy-to-use fourier transform infrared (FTIR) reaction monitoring system offers an effective alternative to traditional MCT detectors in situations where liquid nitrogen is too costly or unsafe for routine use.

Additionally, by eliminating alignment, gas purge and maintenance, faster, simplified set-up is achieved which can significantly reduce long-term lab operating expenses.

Along with easier set-up and less maintenance, customers have the same functional performance from the solid-state SE MCT that they would by using a nitrogen-cooled model.

The size, weight and design of ReactIR™ 15-and, with SE, the absence of nitrogen-handling concerns-enables easy transfer from hood-to-hood or lab-to-lab and with  a wide range of sampling technology, operators can begin experimentation immediately.

Ease-of-use is further enhanced for experiments running longer than 24 hours because no refilling of the dewar is required.

Coupled with Mettler Toledo iC IR™ software, ReactIR™ 15 offers immediate insight into reaction initiation, endpoint, mechanism, pathway and kinetics required for successful compound development.

Users can even set an automatic shut-down the instruments user preferences to extend the reactor’s working lifetime, further protecting the lab’s capital investment.

Adding iC Kinetics™ provides an in-depth graphic visualization of reaction characteristics.

Based on the results, operators can make decisions regarding experiment optimization quickly, enhancing speed-of-development in today’s competitive organic chemistry marketplace.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,000+ scientific posters on ePosters
  • More Than 4,500+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

METTLER TOLEDO Announces a New Symposium on Process Chemistry and Scale-Up
Company has announced that the discover methods entitled Process Chemistry and Scale-up Online Seminar featuring R&D scientists from Air Products and Nalas Engineering.
Wednesday, March 16, 2016
The Art of Pipetting
Sculptor and installation artist Mitra Fabian has created an iceberg sculpture made from recycled pipette tips.
Friday, February 05, 2016
13 Ways to Stop an Unseen Force from Disrupting Weighing
Download a free Mettler Toledo paper to discover how to halt static’s negative effects before the next weigh-in.
Saturday, October 03, 2015
Lab Scale Manufacturing Using Continuous Crystallization
A new METTLER TOLEDO On-demand webinar explores recent research that could revolutionize pharmaceutical production.
Tuesday, April 15, 2014
Mettler-Toledo Awarded Foreign Designated Manufacturer Certification
Mettler Toledo is the first balance manufacturer to win FDM certification in Japan.
Friday, July 26, 2013
Free Webinar Explores Safe Scaling of Pressure Reactions
Robust in situ technology allows cost effective scale-up pressure reactions.
Friday, May 24, 2013
Pharma Tech Trends and Development Cost Solutions
METTLER TOLEDO’s new on-demand webinar, “Methods to Improve Chemical Process Development,” takes on the challenges of today’s pharmaceutical market.
Thursday, April 04, 2013
Mettler-Toledo and Konica Minolta Join Forces
Strategic partnership in the field of multi-parameter analysis for the Flavours & Fragrances industry.
Friday, May 18, 2012
Scientific News
The Rise of 3D Cell Culture and in vitro Model Systems for Drug Discovery and Toxicology
An overview of the current technology and the challenges and benefits over 2D cell culture models plus some of the latest advances relating to human health research.
Scientists Find Evidence That Cancer Can Arise Changes
Researchers at Rockefeller University have found a mutation that affects the proteins that package DNA without changing the DNA itself can cause a rare form of cancer.
Immune Cells Remember Their First Meal
Scientists at the University of Bristol have identified the trigger for immune cells' inflammatory response – a discovery that may pave the way for new treatments for many human diseases.
A New Platform for Discovering Antibiotics
Harvard chemists hope to shorten time, difficulty in measuring their effectiveness, potential.
Biosensor Detects Molecules Linked to Cancer, Alzheimer's and Parkinson's
Novel biosensor has been proven capable of detecting molecules associated with neurodegenerative diseases and some types of cancer.
Gene That Lowers Heart Attack Risk Identified
Individuals with a rare twelve-letter deletion from a gene on chromosome 17 have significantly reduced non-HDL cholesterol levels and a 35% lower than average risk of heart disease.
Non-Toxic Approach to Treating Variety of Cancers
A team of researchers at Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine recently discovered a novel, non-toxic approach to treating a wide variety of cancers.
"Sunscreen" Gene May Guard Against Melanoma
USC-led study reveals that melanoma patients with deficient or mutant copies of the gene are less protected from harmful ultraviolet rays.
Real-Time Imaging of Embryo Development Could Pave the Way
Researchers at IMCB have developed advanced microscopy technologies to monitor embryo development for more effective human reproduction therapies.
Testing Non-Breast/Ovarian Cancer Genes
Researchers have found that expanding gene panel beyond breast/ovarian cancer genes in these patients does not add any clinical benefit. Instead, testing has produced more questions than answers.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,000+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,500+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!